Cargando…
Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis: how far are we from a clinical treatment?
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive muscular atrophy and death within 3–5 years after its onset. Despite the significant advances in knowledge of ALS pathology, no effective treatment is available. Therefore, it is imperative to search for...
Autores principales: | Gubert, Fernanda, Satiago, Marcelo F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020809/ https://www.ncbi.nlm.nih.gov/pubmed/27651758 http://dx.doi.org/10.4103/1673-5374.189167 |
Ejemplares similares
-
Correction: Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis: how far are we from a clinical treatment?
Publicado: (2016) -
Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis
por: Gubert, Fernanda, et al.
Publicado: (2016) -
DNA plasticity and damage in amyotrophic lateral sclerosis
por: Penndorf, Diane, et al.
Publicado: (2018) -
Current view and perspectives in amyotrophic lateral sclerosis
por: Mathis, Stéphane, et al.
Publicado: (2017) -
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020)